Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Inflammation

Inflammation

Immune Surveillance by NK Cells and Phagocytes

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A modular framework for automated segmentation and analysis of AFM imaging of chromatin organization.

Nucleic acids research·2026

Same author

Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1-BH4-iNOS axis.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same author

Comparing Spider Sampling Methods in a Eucalypt Forest in Wet and Dry Conditions.

Animals : an open access journal from MDPI·2026

Same author

IL4i1 activity generates oncometabolites that rescue neuroblastoma cells from oxidative death.

Cell reports·2026

Same author

Cysteine availability tunes ubiquitin signaling via inverse stability of LRRC58 E3 ligase and its substrate CDO1.

Nature communications·2026

Same author

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

Nature chemistry·2026

Search research articles

Related Experiment Video

Updated: Feb 23, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Nonresolving macrophage-mediated inflammation in malignancy.

Peter J Murray¹

¹Immunoregulation Group, Max-Planck-Institut für Biochemie, Martinsried, Germany.

The FEBS Journal

|September 1, 2017

Summary

This summary is machine-generated.

Macrophages, dominant myeloid cells in cancer, often promote tumor growth. Targeting their specific pro-tumor pathways, not the cells themselves, offers a promising strategy to enhance cancer immunotherapies and overcome clinical barriers.

Keywords:

CSF-1 M2 macrophage STAT6 cancer hypoxia immunosuppression macrophage myeloid cell

More Related Videos

A Macrophage-Tumor Spheroid Co-Invasion Assay

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on: January 24, 2025

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Related Experiment Videos

Last Updated: Feb 23, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

A Macrophage-Tumor Spheroid Co-Invasion Assay

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on: January 24, 2025

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Area of Science:

Immunology
Oncology
Cancer Research

Background:

Tumors contain diverse immune cells with pro- or antitumor functions.
Macrophages are the most abundant myeloid cells in cancer, often exhibiting protumor roles.
Understanding macrophage roles is crucial for improving cancer therapies.

Purpose of the Study:

Investigate macrophage-cancer relationships across different cancer types.
Identify specific macrophage properties driving protumor functions.
Evaluate strategies to modulate macrophage activity for enhanced cancer treatment.

Main Methods:

Review of existing preclinical and clinical data on macrophage-targeted cancer therapies.
Analysis of the tumor microenvironment and immune cell interactions.
Exploration of specific molecular pathways utilized by protumor macrophages.

Main Results:

Macrophages are key players in the tumor microenvironment, often suppressing anti-tumor immunity.
Directly targeting macrophages has faced significant clinical challenges.
Specific protumor pathways, rather than macrophages broadly, are viable therapeutic targets.

Conclusions:

Targeting specific macrophage-driven pathways presents a more effective strategy than targeting macrophages themselves.
This approach holds promise for basic research and developing novel cancer therapeutics.
Modulating the tumor microenvironment by targeting macrophage functions can enhance existing cancer therapies.